Showing 1551-1560 of 1564 results for "".
- Allergan to Present Two Podium Presentations on Bimatoprost Sustained-Release (SR) at ASCRShttps://modernod.com/news/allergan-to-present-two-podium-presentations-on-bimatoprost-sustained-release-sr-at-ascrs/2476546/Allergan will present new data for its investigational implant, Bimatoprost SR, and a late-breaking analysis on its subconjunctival gelatin implant, XEN Gel Stent, at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in San Diego, from
- Alcon to Showcase New Clinical Data, Innovative Technology at ASCRShttps://modernod.com/news/alcon-to-showcase-new-clinical-data-innovative-technology-at-ascrs/2476542/Alcon will feature new clinical data along with innovative product designs and technology for the Cataract Refractive Suite during the American Society of Cataract and Refractive Surgery (ASCRS) 2019 annual meeting, taking place May 3-7 in San Diego. The company, which recently became an independ
- The Winning Pitch Challenge Featured at ASCRShttps://modernod.com/news/the-winning-pitch-challenge-featured-at-ascrs/2476539/The Winning Pitch Challenge will feature contestants with innovative ophthalmic ideas presenting to a panel of industry leaders on Sunday, May 5 at the annual American Society of Cataract and Refractive Surgery (ASCRS) conference in San Dieg
- Aerie Pharmaceuticals Matches ASCRS Foundation Fund Raising to Provide Sight-Saving Surgeryhttps://modernod.com/news/aerie-pharmaceuticals-matches-ascrs-foundation-fund-raising-to-provide-sight-saving-surgery/2476538/Aerie Pharmaceuticals announced that it is matching, dollar for dollar, the first $30,000 donated to the ASCRS Foundation’s charitable eye care programs by attendees at the 2019 ASCRS-ASOA Annual Meeting, being held in San Diego, from May 3-7, 2019. This is the second year that Aerie is d
- ImprimisRx to Introduce New Formulations at Cataract & Refractive Surgery Annual Meetinghttps://modernod.com/news/imprimisrx-to-introduce-new-formulations-at-cataract-refractive-surgery-annual-meeting/2476518/ImprimisRx announced its participation at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting to be held at the San Diego Convention Center in San Diego, May 3-7, 2019. At the conference, attendees will have the opportunity to meet with ImprimisRx representative
- LensGen Will Present Early Results Of International “Grail” Study At ASCRShttps://modernod.com/news/lensgen-will-present-early-results-of-international-grail-study-at-ascrs/2476515/LensGen will share results from its “Grail” study at the ASCRS annual meeting in San Diego, May 3-7. The results will include the latest available data on patients who have been treated at two international sites.
- Iridex’s MicroPulse Laser Technology Featured in Several Glaucoma and Retina Research Presentationshttps://modernod.com/news/iridexs-micropulse-laser-technology-featured-in-several-glaucoma-and-retina-research-presentations/2476514/Iridex announced that its patented MicroPulse technology played a pivotal role in research presented at the 2019 Association for Research in Vision & Ophthalmology (ARVO) and American Society of Cataract & Refractive Surgeons (ASCRS) meetings, to be held in Vancouver and San Diego, respec
- Ziemer USA Sponsors NIIOS USA Cornea Eveninghttps://modernod.com/news/ziemer-usa-sponsors-niios-usa-cornea-evening-2/2476495/Ziemer USA is sponsoring the Netherlands Institute for Innovative Ocular Surgery (NIIOS) Cornea Evening in San Diego, California, on Friday, May 3, 2019, from 6-11 pm. For the third year in a row, NIIOS USA is organizing a Cornea Evening preceding the Annual Meeting of the American Society
- Higher Calcium Intake Tied to Slower AMD Progressionhttps://modernod.com/news/higher-calcium-intake-tied-to-slower-amd-progression/2479580/Higher levels of dietary and supplementary calcium intake are associated with a lower risk of progression to late age-related macular degeneration (AMD), according to a secondary analysis of data from a large trial, as reported by Reuters.
- Study Examines Using Re-Esterified Omega-3 and Maqui Berry in Combination as a Treatment for Dry Eye Diseasehttps://modernod.com/news/study-examines-using-re-esterified-omega-3-and-maqui-berry-in-combination-as-a-treatment-for-dry-eye-disease/2476402/Focus Laboratories has announced that a clinical study on their VitaSight O3+Maqui Dietary Supplement, conducted by Edward Paul, PhD, was published in the Journal of Clinical & Experiment